NCT01111175 - Triple Negative Breast Cancer Biomarker Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions

Metastatic Breast CancerTriple Negative Breast Cancer

Trial Locations (18)

Virginia Oncology Associates, Williamsburg

Virginia Oncology Associates, Chesapeake

Virginia Oncology Associates, Virginia Beach

Virginia Oncology Associates, Norfolk

Virginia Oncology Associates, Newport News

Virginia Oncology Associates, Hampton

Virginia Oncology Assocites, Elizabeth City

Texas Oncology-Dallas Presbyterian Hospital, Dallas

Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas

Texas Oncology - Tyler, Tyler

Texas Oncology-Memorial City, Houston

Rocky Mountain Cancer Centers, Denver

Northwest Cancer Specialists, P.C., Tualatin

Northwest Cancer Specialists, P.C., Portland

Northwest Cancer Specialists, P.C., Portland

Northwest Cancer Specialists, P.C., Portland

Northwest Cancer Specialists, P.C., Vancouver

Northwest Cancer Specialists, P.C., Vancouver